Transmission electron micrograph of SARS-CoV-2 virus particles captured by NIAID
The AI model uses data from the COVID Symptom Study app to predict COVID-19 infection.
Researchers at King’s College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based on their symptoms. Their findings are published today in Nature Medicine.
The AI model uses data from the COVID Symptom Study app to predict COVID-19 infection, by comparing people’s symptoms and the results of traditional COVID tests. Researchers say this may provide help for populations where access to testing is limited. Two clinical trials in the UK and the US are due to start shortly.
More than 3.3 million people globally have downloaded the app and are using it to report daily on their health status, whether they feel well or have any new symptoms such as persistent cough, fever, fatigue and loss of taste or smell (anosmia).
In this study, the researchers analysed data gathered from just under 2.5 million people in the UK and US who had been regularly logging their health status in the app, around a third of whom had logged symptoms associated with COVID-19. Of these, 18,374 reported having had a test for coronavirus, with 7,178 people testing positive.
The research team investigated which symptoms known to be associated with COVID-19 were most likely to be associated with a positive test. They found a wide range of symptoms compared to cold and flu, and warn against focusing only on fever and cough. Indeed, they found loss of taste and smell (anosmia) was particularly striking, with two thirds of users testing positive for coronavirus infection reporting this symptom compared with just over a fifth of the participants who tested negative. The findings suggest that anosmia is a stronger predictor of COVID-19 than fever, supporting anecdotal reports of loss of smell and taste as a common symptom of the disease.
The researchers then created a mathematical model that predicted with nearly 80% accuracy whether an individual is likely to have COVID-19 based on their age, sex and a combination of four key symptoms: loss of smell or taste, severe or persistent cough, fatigue and skipping meals. Applying this model to the entire group of over 800,000 app users experiencing symptoms predicted that just under a fifth of those who were unwell (17.42%) were likely to have COVID-19 at that time.
Researchers suggest that combining this AI prediction with widespread adoption of the app could help to identify those who are likely to be infectious as soon as the earliest symptoms start to appear, focusing tracking and testing efforts where they are most needed.
Our results suggest that loss of taste or smell is a key early warning sign of COVID-19 infection and should be included in routine screening for the disease. We strongly urge governments and health authorities everywhere to make this information more widely known, and advise anyone experiencing sudden loss of smell or taste to assume that they are infected and follow local self-isolation guidelines.– Professor Tim Spector, King’s College London
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Gartner predicts rise of distributed data architectures, smarter AI and accelerated automation
The pandemic’s push to remote and hybrid work will drive a raft of new distributed data and services and more automation over the next five to 10 years. That’s among the predictions tech industry ...
- Artificial Intelligence (AI) In Diagnostics Market size worth $ 5371.11 Million, Globally, by 2028 at 33.23% CAGR: Verified Market Research®
and cost reductions are some of the major factors expected to drive the growth of the market for AI in diagnostics during the forecast period. Moreover, the high demand for e-diagnostic services in ...
- Neuron Bursts Can Mimic Famous AI Learning Strategy
A new model of learning centers on bursts of neural activity that act as teaching signals — approximating backpropagation, the algorithm behind learning in AI.
- AI data offers reliable 14 day Covid admissions forecast
Forecasting the daily number of near-term Covid-19 admissions has been a vital part of hospital planning during the pandemic. New research has now shown ...
- AI predicts extensive material properties to break down a previously insurmountable wall
If the properties of materials can be reliably predicted, then the process of developing new products for a huge range of industries can be streamlined and accelerated. In a study published in ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
AI predicting COVID-19 infection
- Tackling Medical Emergencies During The Pandemic: A Comprehensive Guide
Medical emergencies have been common for as long as humans have existed. These cases can be fatal if not handled early enough, and ...
- Ondansetron use associated with increased survival in mechanically ventilated COVID-19 patients
A recent study analyzes real-world data using artificial intelligence to provide insights into using ondansetron, an antiemetic agent, among SARS-CoV-2 positive patients.
- Health Data: Tracking, managing, and improving lives
Health data has long been ripe for innovation through predictive analytics. Due to continuous monitoring with smart wearables, clinical trials, claims, patient-reported medical data, availability of ...
- Healthcare infrastructure needs a check-up
Data passing through the hospital systems and databases must be digitised and harmonised to truly transform the healthcare infrastructure Reports of shortages of hospital beds, ventilators, medical eq ...
- Evaxion Biotech to Present Work on AI-Immunology Core Technology at Immuno UK 2021
Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the“Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients ...